About The Medical Condition Drug Evaluation, FDA Phase II
Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase II
| Drug Evaluation, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Guanine Nucleotide Exchange Factors ‐ Protein factors that promote the exchange of GTP for GDP bound…
- Rheumatic Chorea ‐ Acquired and hereditary conditions which feature CHOREA as a…
- Transitional Cell Carcinoma ‐ A malignant neoplasm derived from transitional epithelium, occurring…
- Hydroxymethylbilane Synthetase ‐ An enzyme that catalyzes the formation of hydroxymethylbilane…
- Cervical Ripening ‐ A change in the cervix with respect to its readiness to relax.…
- Evaluations ‐ Studies determining the effectiveness or value of processes,…
- Chromaffin Cell ‐ Cells that store epinephrine secretory vesicles. During times…
- Glutathione S-Transferase 3 ‐ A transferase that catalyzes the addition of aliphatic, aromatic,…
- Alveolodental Membranes ‐ Fibrous connective tissue surrounding the root of a tooth that…
- Soft Tissue Sarcomas ‐ A connective tissue neoplasm formed by proliferation of mesodermal…